Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $13.25 Analyst target: $14.67 Upside: 10.72%
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health, eye health, gastrointestinal disease, and toxicology applications globally. The company is headquartered in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.